Form 4 for LLY Lilly (Eli)
Accepted 2026-02-18 00:00:00 ET · period of report 2026-02-16 · accession 0002096888-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-18 | 2026-02-16 | LLY | Brown Adrienne S | EVP, Pres LLY Imm | M - OptEx | $0.00 | +391 | 5,312 | +8% | $0 |
| D | 2026-02-18 | 2026-02-16 | LLY | Brown Adrienne S | EVP, Pres LLY Imm | F - Tax | $1,040.00 | -169.97 | 5,142 | -3% | -$176.8K |
| D | 2026-02-18 | 2026-02-16 | LLY | Brown Adrienne S | EVP, Pres LLY Imm | M - OptEx | $0.00 | -391 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-16 | M | A | 391 | $0.00 | 5,312.31 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-16 | F | D | 169.97 | $1,040.00 | 5,142.34 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2026-02-16 | M | D | 391 | $0.00 | 0 | D | — · 2026-02-16 to 2026-02-16 | 391 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |